4-Ethylpiperazin-2-one hydrochloride

Catalog No.: 
ACHZYS835
CAS No.: 
65464-00-8
Molecular Formula: 
C6H13ClN2O
Molecular Weight: 
164.64
4-Ethylpiperazin-2-one hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$54.00In stockInquiry
1g97%$77.00In stockInquiry
5g97%$230.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Ethylpiperazin-2-one hydrochloride
IUPAC Name4-ethylpiperazin-2-one hydrochloride
MDL No.MFCD22422017
Molecular FormulaC6H13ClN2O
Molecular Weight164.64
SMILESO=C1NCCN(CC)C1.[H]Cl
InChI KeyNSWOBMIYJFZIIS-UHFFFAOYSA-N
Synonym4-Ethylpiperazin-2-one hydrochloride;Piperazinone, 4-ethyl-, monohydrochloride
CAS No.65464-00-8
PubChem CID75539471

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACHZYS835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCXNG132 route compound structure diagram
    ACCXNG1325625-67-2In Stock
  4. Then
  5. ACHZYS835 route product structure diagram
    ACHZYS83565464-00-8In Stock
Inquiry

2. ACHZYS835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCXNG132 route compound structure diagram
    ACCXNG1325625-67-2In Stock
  4. Then
  5. ACHZYS835 route product structure diagram
    ACHZYS83565464-00-8In Stock
Inquiry

3. ACHZYS835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCXNG132 route compound structure diagram
    ACCXNG1325625-67-2In Stock
  4. Then
  5. ACHZYS835 route product structure diagram
    ACHZYS83565464-00-8In Stock
Inquiry

Comments (0)